Biotech startup co-founded by MIT’s Feng Zhang unveils new CRISPR tool

Arbor Biotechnologies disclosed a round of financing last June, but has kept the nature of its research a mystery — until Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.